Former CMS Administrator Mark McClellan suggested that CMS consider including drug spending in alternative pay models, such as medical homes and accountable care organizations, to help curb rising specialty drug prices. That approach might be a way to deal with drugs in Part B, which isn't set up for outcomes-based contracts, unlike Part D. Speaking at the HHS Pharmaceutical Forum on Friday (Nov. 20), McClellan outlined many policies to curb drug prices that either have been used or considered. Outcomes-based...